Leptin: From laboratory to clinic

Handbook of Obesity: Clinical Applications

Volumn , Issue , 2003, Pages 275-295

  Caro, José F ^a   Considine, Robert V ^b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19344366634     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (160)

1. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc B 1953; 140:578-592.
2. Hervey GR. The effects of lesions in the hypothalamus in parabiotic rats. J Physiol 1959; 145:336-352.
3. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14:141-148.
4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
5. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, SelentMunro C, Tepper RI. Identification and expression cloning of the a leptin receptor. OB-R Cell 1995; 83: 1263-1271.
6. Chen H, Chariat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84:491-495.
7. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379:632-635.
8. Cohen SL, Halass JL, Friedman JM, Chait BT. Human leptin characterization. Nature 1996; 382:589.
9. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW. Insulin stimulates both leptin secretion and production by white adipose tissue. Endocrinology 1997; 138:4463-4472.
10. Bradley RL, Cheatham B. Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes. Diabetes 1999; 48:272-278.
11. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord 2001; 2:357-363.
12. Tartaglia LA. The leptin receptor. J Bioi Chern 1997; 272:6093-6096.
13. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM. Leptin activation of STAT3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14:95-97.
14. Bjorbaek C, Uotani S, Da Silva B, Flier JS. Divergent signaling capacites of the long and short isoforms of the leptin receptor. J Bioi Chern 1997; 272:32686-32695.
15. Wang M-Y, Zhou YT, Newgard CB, Unger RH. A novelleptin receptor isoform in rat. FEBS Lett 1996; 392:87-90.
16. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17:305-311.
17. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. J Clin Invest 1997; 99:14-18.
18. Hileman SM, Tornoe J, Flier JS, Bjorbaek C. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-DarbY canine kidney cells. Endocrinology 2000; 141:1955-1961.
19. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98:1277-1282.
20. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996; 45:1638-1643.
21. Huang L, Wang Z, Li C. Modulation of circulating leptin levels by its soluble receptor. J BioI Chem 2001; 276:6343-6349.
22. Gavrilova O, Barr V, Marcus-Samuels B, Reitman M. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Bioi Chem 1997; 272:30546-30551.
23. Lewandowski K, Horn R, O’Callaghan CJ, Dunlop D, Medley GF, O’Hare P, Brabant G. Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab 1999; 84:300-306.
24. Moon BC, Friedman JM. The molecular basis of the obese mutation in ob2j mice. Genomics 1997; 42:152-156.
25. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93:6231-6235.
26. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev 1998; 56:S38-S48.
27. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996; 13:18-19.
28. Chua SC Jr, White DW, Wu-Peng S, Liu SM, Okada N, Kershaw EE, Chung WK, Power-Kehoe L, Chua M, Tartaglia L, Leibel RL. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Jepr). Diabetes 1996; 45:1141-1143.
29. White DW, Wang DW, Chua SC Jr, Morgenstern JP, Leibel RL. Constituitive and impaired signaling of leptin receptors containing the GIn-Pro extracellular domain mutation. Proc Natl Acad Sci USA 1997; 94: I0657-1 0662.
30. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 1996; 14:130-131.
31. Wu-Peng S, Chua SC Jr, Okada N, Lui SM, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma to CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 1997; 46:513-518.
32. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-543.
33. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-546.
34. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a periperal signal linking adiposity and central neural networks. Science 1995; 269:546-549.
35. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377:530-532.
36. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96:2065-2070.
37. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45:531-535.
38. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1:1155-1161.
39. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-Ieptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-295.
40. Hassink SG, Sheslow DV, De Lancey E, Opentanova I, Considine RV, Caro JE. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996; 98:201-203.
41. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones and pubertal stage. J Clin Endocrinol Metab 1997; 82:2849-2855.
42. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997; 82:2904-2910.
43. Argente J, Barrios V, Chowen JA, Sinha MK, Considine RV. Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa. J Pediatr 1997; 131:833-838.
44. Hassink SG, deLancey E, Sheslow DV, Smith-Kirwin SM, O’Connor DM, Considine RV, Opentanova I, Dostal K, Spear ML, Leef K, Ash M, Spitzer AR, Funanage VL. Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics 1997; 100:el.
45. Tome MA, Lage M, Camina JP, Garcia-Mayor RV, Dieguez C, Casanueva FF. Sex-based differences in serum leptin concentrations from umbilical cord blood at delivery. Eur J Endocrinol 1997; 137:655-658.
46. Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, Attanasio A, Blum WF. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997; 82:1480-1483.
47. Hegele RA, Cao H, HuffMW, Anderson CM. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endocrinol Metab 2000; 85:3089-3093.
48. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995; 1:953-956.
49. Lonnqvist F, Nordfors L, Jansson M, Thorne A, Schalling M, Arner P. Leptin secretion from adipose tissue of women. Relatioship to plasma levels and gene expression. J Clin Invest 1997; 99:2398-2404.
50. Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL, Houmard JA, Marks RHL, Caro JF. Gender differences in serum leptin levels in humans. Biochem Mol Med 1996; 59:1-6.
51. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81:3424-3427.
52. Rosenbaum M, Leibel RL. Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab 1999; 84:1784-1789.
53. Montague CT, Prins JB, Sanders L, Digby J, Orahilly S. Depot and sex specific differences in human leptin mRNA expression. Diabetes 1997; 46:342-347.
54. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 1998; 47:98-103.
55. Van Harmelen V, Reynisdotir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue of women. Diabetes 198; 47:913-917.
56. Fried SK, Kral JG. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes 1987; 11:129-140.
57. Fried S, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92:2191-2198.
58. Sih R, Morley JE, Kaiser FE, Perry HMIII, Patrick P, Ross C. Testosterone replacement in older hypogondal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82:1661-1667.
59. Jockenhovel F, Blum WF, Vogel E, Englaro P, Muller-Wieland D, Reinwein D, Rascher W, Krone W. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 1997; 82:2510-2513.
60. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997; 82:1066-1070.
61. Elbers JM, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJ. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 1997; 82:2370-3267.
62. Casabiell X, Pineiro V, Peino R, Lage M, Camina JP, Gallego R, Vallejo LG, Dieguez C, Casanueva FF. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 1998; 83:2149-2155.
63. Pineiro V, Casabiell X, Peino R, Lage M, Camina JP, Menendez C, Baltar J, Dieguez C, Casanueva FF. Dihydrotestosterone, stanozol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not male samples of omental adipose tissue in vitro: lack of effect of testosterone. J Endocrinol 1999; 160:425-432.
64. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45:1455-1462.
65. Sinha M, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF. Nocturnal rise of leptin in lean, obese, and non-insulindependent diabetes mellitus subjects. J Clin Invest 1996; 97:1344-1347.
66. Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF. Responses ofleptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 1996; 45:1511-1515.
67. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum 1eptin in normal human subjects. J Clin Endocrinol Metab 1996; 81:3419-3423.
68. Wisse BE, Campfield LA, Marliss EB, Morais JA, Tenenbaum R, Gougeon R. Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women. Am J Clin Nutr 1999; 70:321-330.
69. Schoeller DA, Cella LK, Sinha MK, Caro JF. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997; 100:1882-1887.
70. Havel PJ, Townsend R, Chaump L, Teff K. High fat meals reduce 24 h circulating leptin concentrations in women. Diabetes 1999; 48:334-341.
71. Saad MF, Khan A, Sharma A, Michael R, RoadGabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V. Physiological insulinemia acutely modulates plasma 1eptin. Diabetes 1998; 47:544-549.
72. Utriainen T, Malmstrom R, Makimattila S, YkiJarvinen H. Supraphysio10gica1 hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes 1996; 45:1364-1366.
73. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 1998; 139:551-558.
74. Mueller W, Stanhope K, Gregoire FM, Evans JL, Havel PJ. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 2000; 8:530-539.
75. Rossetti L. Perspective: hexosamines and nutrient sensing. Endocrinology 2000; 141:1922-1925.
76. Wells L, Vosseller K, Hart GW. Glycosy1ation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001; 291:2376-2378.
77. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates 1eptin gene expression in muscle and fat. Nature 1998; 393:684-688.
78. McClain DA, Alexander T, Cooksey RC, Considine RV. Hexosamines stimulate 1eptin production in transgenic mice. Endocrinology 2000; 141: 1999-2002.
79. Considine RV, Cooksey RC, Williams LB, Fawcett RL, Zhang P, Ambrosius WT, Whitfield RM, Jones RM, Inman M, Huse J, McClain DA. Hexosamines regulate 1eptin production in human subcutaneous adipocytes. J C1in Endocrinol Metab 2000; 85:3551-3556.
80. Levy JR, Gyarmati J, Lesko JM, Adler RA, Stevens W. Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway. Am J Physiol Endocrinol Metab 2000; 278:E892-E901.
81. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82:4139-4143.
82. Pinkney JH, Coppack SW, Mohamed Ali V. Effect of isoproterenol on plasma 1eptin and lipolysis in humans. Clin Endocrino1 (Oxf) 1998; 48:407-411.
83. Stumvoll M, Fritsche A, Tschritter O, Lehmann R, Wahl HG, Renn W, Haring H. Leptin levels in humans are acutely suppressed by isoproterenol despite acipomox- induced inhibition of lipolysis, but not by free fatty acids. Metabolism 2000; 49:335-339.
84. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuiei F, Manetta J, Bue-Valleskey J, Stephens TW. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Bioi Chem 1996; 271:5301-5304.
85. 3 radrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996; 45:909-914.
86. 3 -adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137:4054-4057.
87. Collins S, Surwit RS. Pharmacologic manipulation of ob expression in a dietary model of obesity. J Bioi Chem 1996; 271:9437-9440.
88. Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a Gs protein-coupled pathway in 3T3-Ll adipocytes. Diabetes 1996; 45:1744-1749.
89. Ricci MR, Fried SK. Isoproterenol decreases leptin expression in adipose tissue of obese humans. Obes Res 1999; 7:233-240.
90. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S. Congenital1eptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908.
91. Rau H, Reaves BJ, O’Rahilly S, Whitehead JP. Truncated human leptin (delta 133) associated with extreme obesity undergoes proteasoma1 degradation after defective intracellular transport. Endocrinology 1999; 140: 1718-1723.
92. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18:213-215.
93. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398-401.
94. Lahlou N, Clement K, Carel JC, Vaisse C, Lotton C, Le Bihan Y, Basdevant A, Lebouc Y, Froguel P, Roger M, Guy-Grand B. Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes 2000; 49:1347-1352.
95. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382:250-252.
96. Flier JS. What’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab 1998; 83:1407-1413.
97. Wadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB, Caro JF. Short and long term changes in serum leptin in dieting obese women: Effects of caloric restriction and weight loss. J Clin Endocrinol Metab 1998; 83:214-218.
98. Kolaczynski JW, Ohannesian J, Considine RV, Marco C, Caro JF. Response of leptin to short term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996; 81:4162-4165.
99. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 1997; 3:238-240.
100. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45:984-987.
101. Sharma K, Considine RV, Michael R, Dunn SR, Weisberg L, Kurnik P, O’Conner J, Sinha M, Caro JF. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51:1980-1985.
102. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82:847-850.
103. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17:305-311.
104. Hileman SM, Tornoe J, Flier JS, Bjorbaek C. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-DarbY canine kidney cells. Endocrinology 2000; 141:1955-1961.
105. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinalfluid serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
106. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2:589-593.
107. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997; 99:385-390.
108. EI-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000; 105: 1827-1832.
109. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998; I: 445-450.
110. Elmquist JK, Elias CR, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999; 22:221-232.
111. Chen XP, Losman JA, Rothman P. SOCS proteins, regulators of intracellular signalling. Immunity 2000; 13:287-290.
112. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 191:619-625.
113. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes JA, McCamish MA, O’Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341:879-884.
114. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kusher R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. Recombinant leptin for weight Loss in obese and lean adults. JAMA 1999; 282:1568-1575.
115. Fujika K, Patane J, Lubina J, Lau D. Research Letter:CSF leptin levels after exogenous administration of recombinant methionyl human leptin. JAMA 1999; 282:1517-1518.
116. Hukshorn CJ, Saris WHM, Westerterp-Plantenga S, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration III obese men. J Clin Endocrinol Metab 2000; 85:4003-4009.
117. Mantzoros CS, Flier JS. Editorial: Leptin as a therapeutic agent-trials and tribulations. J Clin Endocrinol Metab 2000; 85:4000-4002.
118. Bray GA, Tartaglia LA. Medicinal strategies in the treatment of obesity. Nature 2000; 404:672-677.
119. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997; 138:3395-3401.
120. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389:374-377.
121. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401:73-76.
122. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML, Nakao K Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipatrophic diabetes. Diabetes 2001; 50:1440-1448.
123. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274:1185-1188.
124. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272:10585-10593.
125. Zierath JR, Frevert EU, Ryder JW, Berggren P, Kahn BB. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 1998; 47:1-1.
126. Furnsinn C, Brunmair B, Furtmuller R, Roden M, Englisch R, Waldhausl W. Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro. Diabetologia 1998; 41:524-529.
127. Ranganathan S, Ciaraldi TP, Henry RR, Mudaliar S, Kern PA. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells. Endocrinology 1998; 139:2509-2513.
128. 12 myolubes: evidence for a PI3-kinase mediated effect. Diabetologia 1997; 40:606-609.
129. Williams LB, Ohannesian DW, Kogon BE, Jones RM, Inman M, Huse J, Considine RV. Leptin increases basal and insulin-stimulated glucose uptake into human subcutaneous adipocytes. Diabetes 1998; 47 (suppl i):A73.
130. Kim Y-B, Uotai S. Pierroz DD, Flier JS, Kahn BB. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 2000; 141:2328-2339.
131. Arioglu E, Simha V. Andewelt A, Ruiz E, Snell P. Depaoli A, Wagner A, Reitman M, Taylor SI, Gorden P, Garg A. Treatment of patients with lipoatrophy: efficacy of leptin treatment. 1st International Workshop on Lipoatrophic Diabetes. National Institutes of Health, Bethesda, MD, March 22-23, 2001.
132. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100:2858-2864.
133. Shimabukuro M, Koyama K, Chen G. Wang MY, Trieu F. Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94:4637-4641.
134. Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 1997; 240:590-594.
135. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem 1999; 274:17541-17544.
136. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996; 12:318-320.
137. Barash IA. Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL, Clifton DK. Steiner RA. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996; 137:3144-3147.
138. Ahima RS. Dushay J, Flier SN. Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997; 99:391-395.
139. Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action on insulin-like growth factor I on follicle stimulating hormone dependent estradiol 17 beta production by rat ovarian granulosa cells. Endocrinology 1997; 138:847-850.
140. Suter KJ, Pohl CR, Wilson ME. Circulating concentrations of nocturnal leptin, growth hormone, and insulinlike growth factor-I increase before the onset of puberty in agonadal male monkeys: potential signals for the initiation of puberty. J Clin Endocrinol Metab 2000; 85: 808-814.
141. Matkovic V, Ilich JZ, Skugor M, Badenhop NE, Goel P, Clairmont A, Klisovic D. Nahhas RW, Landoll JD. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997; 82:3239-3245.
142. Butte NF, Hopkinson JM, Nicolsol MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997; 82:585-589.
143. Hardie L. Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol 1997; 47:101-106.
144. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998; 178:1010-1015.
145. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997; 3:1029-1033.
146. Senaris R, Garcia-Caballero T, Casabiell X, Gallego R. Castro R, Considine RV, Dieguez C, Casanueva FF. Synthesis of leptin in human placenta. Endocrinology 1997; 138:4501-4504.
147. Bi S, Gavrilova O, Gong D-W, Mason MM, Reitman M. Identification of a placental enhancer for the human leptin gene. J Biol Chem 1997; 272:30583-30588.
148. Tomimatsu T, Yamaguchi M, Murakami T, Ogura K, Sakata M. Mitsuda N, Kanzaki T, Kurachi H, Irahara M, Miyake A, Shima K, AonoT, Murata Y. Increase in mouse leptin production by adipose tissue after mid-pregnancy: gestational profile of serum leptin concentration. Biochem Biophys Res Commun 1997; 240:213-215.
149. Kawai M, Yamaguchi M, Murakami T, Shima K, Murata Y, Kishi K. The placenta is not the main source of leptin production in the pregnant rat; gestational profile of leptin in plasma and adipose tissues. Biochem Biophys Res Commun 1997; 240:798-802.
150. Cioffi J A, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR. Novel B219/OB receptor isoforms: possible role of leptin in hema-topoiesis and reproduction. Nat Med 1996; 2:585-589.
151. Bennett DB, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996; 6:1170-1180.
152. Gainsford T. Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ. Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells. Proc Natl Acad Sci USA 1996; 93:14564-14568.
153. Mikhail A, Beck EX. Shafer AW. Barut B, Smith-Gbur J, Zupancic TJ, Schweitzer AC, Cioffi JA, Lacaud G, Ouyang B. Keller G, Snodgrass HR. Leptin stimulates fetal and adult erythroid and myeloid development. Blood 1997; 89:1507-1512.
154. Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997: 11: 393-399.
155. Umemoto Y, Tsuji K. Yang F-C, Ebihara Y, Kaneko A, Furukawa S, Nakahata T. Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic cells. Blood 1997; 90:3438-3443.
156. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394:897-901.
157. Laharrague P, Larrouy D, Fontanilles A-M, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Penicaud L, Casteilla L. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J 1998; 12:747-752.
158. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100:197-207.
159. Considine RV. Considine EL. Williams CJ. Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF. Evidence against either a premature stop codon or the absence of Ob gene mRNA in human obesity. J Clin Invest 1995; 95:2986-2988.
160. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62:413-437.